| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 228,414 | 102,548 | 134,226 | 303,506 | | Cost of Revenue | 130,463 | 61,763 | 75,313 | 166,016 | | | Gross Profit | 97,951 | 40,785 | 58,913 | 137,490 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 44,871 | 36,560 | 39,587 | 52,843 | | Non Recurring |
-
| 1,000 |
-
| 20,925 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 53,080 | 3,225 | 19,326 | 63,722 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (810) | 1,222 | 615 | 839 | | Earnings Before Interest And Taxes | 52,270 | 4,447 | 19,941 | 64,561 | | Interest Expense | (915) | (17) | 17 | (85) | | Income Before Tax | 53,185 | 4,464 | 19,924 | 64,646 | | Income Tax Expense | 19,434 | 1,697 | 7,571 | 24,306 | | Minority Interest | 173 |
-
|
-
| 120 | | | | Net Income From Continuing Ops | 33,924 | 2,767 | 12,353 | 40,460 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 33,924 | 2,767 | 12,353 | 40,460 | | Preferred Stock And Other Adjustments | (99) | 112 | (13) |
-
| | | Net Income Applicable To Common Shares | $33,825 | $2,879 | $12,340 | $40,460 |
|
1.52% Nasdaq 0.00%
Income Statement
